(Q43521470)

24 November 2017

title

Bromocriptine lessens the incidence of mortality in L-dopa-treated parkinsonian patients: prado-study discontinued (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1451713

28 September 2022

1 reference

H. Przuntek

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1451713

28 September 2022

D. Welzel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1451713

28 September 2022

E. Blümner

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1451713

28 September 2022

W. Danielczyk

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1451713

28 September 2022

H. Letzel

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1451713

28 September 2022

H. J. Kaiser

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1451713

28 September 2022

P. H. Kraus

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1451713

28 September 2022

P. Riederer

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1451713

28 September 2022

D. Schwarzmann

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1451713

28 September 2022

H. Wolf

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1451713

28 September 2022

language of work or name

1 reference

1 January 1992

1 reference

European Journal of Clinical Pharmacology

24 November 2017

published in

1 reference

24 November 2017

volume

43

1 reference

24 November 2017

issue

4

1 reference

24 November 2017

page(s)

357-363

1 reference

[Combined treatment of the early stages of Parkinson's syndrome with bromocriptine and levodopa. The results of a multicenter study]

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF02220609

Combined bromocriptine-levodopa therapy early in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02220609

A SELF-RATING DEPRESSION SCALE

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02220609

Early combination of bromocriptine and levodopa in the treatment of Parkinson's disease: a 5-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02220609

Modification of levodopa effect by systemic decarboxylase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02220609

Levodopa in Parkinsonism: Potentiation of Central Effects with a Peripheral Inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02220609

Parkinsonism: onset, progression, and mortality

21 January 2018

1 reference

12 December 2020

Lipid peroxidation as cause of nigral cell death in Parkinson's disease

1 reference

12 December 2020

[Bromocriptin in the treatment of progressive stages of Parkinson's disease (author's transl)]

1 reference

12 December 2020

Primary combination therapy of early Parkinson's disease. A long-term comparison between the combined regimen bromocriptine/levodopa and levodopa monotherapy--first interim report

1 reference

12 December 2020

Treatment of idiopathic parkinsonism with L-dopa in the absence and presence of decarboxylase inhibitors: effects on plasma levels of L-dopa, dopa decarboxylase, catecholamines and 3-O-methyl-dopa

1 reference

12 December 2020

Longtime study on the effects of L-dopa therapy in parkinsonism

1 reference

12 December 2020

Evidence of a Selective Increase in Cardiac Sympathetic Activity in Patients with Sustained Ventricular Arrhythmias

1 reference

12 December 2020

The changing patterns of death rates in parkinsonism.

1 reference

12 December 2020

Parkinsonism treated with levodopa: progression and mortality.

1 reference

12 December 2020

Oxidation reactions in Parkinson's disease.

1 reference

12 December 2020

Ro 4-4602 and levodopa in the treatment of parkinsonism

1 reference

12 December 2020

Reduction in vulnerability to ventricular fibrillation by bromocriptine, a dopamine agonist

1 reference

12 December 2020

Dopaminergic Control of Circadian Norepinephrine Levels in Patients with Essential Hypertension

1 reference

12 December 2020

Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration?

1 reference

12 December 2020

Anesthetic-dopamine cardiac arrhythmias and their prevention by beta adrenergic blockade.

1 reference

12 December 2020

1 reference

12 December 2020

Recent advances in the treatment of Parkinson's disease: the role of bromocriptine

1 reference

12 December 2020

Long-term treatment of parkinsonism with bromocriptine

1 reference

12 December 2020

Critical analysis of the disability in Parkinson's disease

1 reference

12 December 2020

Evaluation of survival data and two new rank order statistics arising in its consideration

1 reference

12 December 2020

[Long-term study of 416 cases of Parkinson disease. Prognostic factors and therapeutic implications]

1 reference

12 December 2020

Acceleration of blood in the aorta: a parameter useful for evaluating cardiotonic and afterload reducing substances

1 reference

12 December 2020

L-dopa therapy of Parkinson's disease: plasma L-dopa concentration, therapeutic response, and side effects

1 reference

12 December 2020

Effects of Bromocriptine on Plasma Catecholamines in Normal Men

1 reference

12 December 2020

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02220609

1 reference

24 November 2017

1 reference